Andrey Semechkin
Principal executive officer pay for Andrey Semechkin, by year and company, from pay-versus-performance disclosure. Every figure links to its source on the company page.
International Stem Cell CORP (ISCO) FY2023–FY2025
Aligned: paid up as stock roseCAP $81,567→$136,470 while $100 invested went $33.33→$175.00
| Fiscal year | SCT total | Comp actually paid |
|---|---|---|
| FY2023 | $112,865 | $81,567 |
| FY2024 | $66,480 | $142,552 |
| FY2025 | $88,544 | $136,470 |
The company's "$100 invested" index ran $33.33 at FY2023 → $175.00 by FY2025 — an annualized return of 129.1%.
Track record
1 measurable tenure in the pay-versus-performance disclosure window. Best annualized TSR: 129.1%/yr at ISCO ( FY2023–FY2025). See the CEO track-record ranking for context.